| 000 | 01854 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516180832.0 | ||
| 264 | 0 | _c20140326 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1558-3597 | ||
| 024 | 7 |
_a10.1016/j.jacc.2013.09.061 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPalmerini, Tullio | |
| 245 | 0 | 0 |
_aClinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. _h[electronic resource] |
| 260 |
_bJournal of the American College of Cardiology _cFeb 2014 |
||
| 300 |
_a299-307 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Review | ||
| 650 | 0 | 4 |
_aCardiovascular Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChromium Alloys |
| 650 | 0 | 4 | _aCoated Materials, Biocompatible |
| 650 | 0 | 4 |
_aCoronary Thrombosis _xepidemiology |
| 650 | 0 | 4 | _aDrug-Eluting Stents |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Infarction _xepidemiology |
| 650 | 0 | 4 |
_aMyocardial Revascularization _xstatistics & numerical data |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aPolymers |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 | _aStents |
| 700 | 1 | _aBiondi-Zoccai, Giuseppe | |
| 700 | 1 | _aDella Riva, Diego | |
| 700 | 1 | _aMariani, Andrea | |
| 700 | 1 | _aSabaté, Manel | |
| 700 | 1 | _aSmits, Pieter C | |
| 700 | 1 | _aKaiser, Christoph | |
| 700 | 1 | _aD'Ascenzo, Fabrizio | |
| 700 | 1 | _aFrati, Giacomo | |
| 700 | 1 | _aMancone, Massimo | |
| 700 | 1 | _aGenereux, Philippe | |
| 700 | 1 | _aStone, Gregg W | |
| 773 | 0 |
_tJournal of the American College of Cardiology _gvol. 63 _gno. 4 _gp. 299-307 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jacc.2013.09.061 _zAvailable from publisher's website |
| 999 |
_c23247817 _d23247817 |
||